bioRxiv / medRxiv
open access
A De Novo, Intragenic Modifier in Cis Rescues Scn8a-N1768D Epilepsy and Defines a Therapeutic Window Bounded by Gain- and Loss-of-Function
Gain-of-function variants in SCN8A, encoding NaV1.6, cause developmental and epileptic encephalopathy with early-onset, drug-resistant seizures. SCN8A is a Goldilocks gene: both excess and deficit of NaV1.6 are deleterious, so therapies that lower NaV1.6 must operate within a narrow window. Here we
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Long-term, Prospective Study Evaluating Clinical and Molecular Biomarkers of Epileptogenesis in a Genetic Model of Epilepsy - Tuberous Sclerosis Complex#850486
- Elicited Repetitive Daily Blindness Associated With Gain-of-Function SCN1A Variants and Responsiveness to Sodium Channel Blockers.#138509
- Engineered BDNF producing cells as a potential treatment for neurologic disease#1373247
- Autism Spectrum Disorder phenotype and underlying pathological mechanisms in mice modeling human mutations of the SCN2A gene#1120661
- Mechanisms of SCN2A loss of function do not predict presence or phenotype of epilepsy.#193360
Record · ID 1306410
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive